Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium
Go back to Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium| (NASDAQ: IMUX) | Delayed: 15.41 +0.11 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.30 | 52 Week High | $ | |||
| Open | $15.20 | 52 Week Low | $ | |||
| Day High | $15.78 | P/E | N/A | |||
| Day Low | $14.98 | EPS | $ | |||
| Volume | 288,833 | |||||
